Growth & Expansion Althea has demonstrated significant growth by expanding its facilities in San Diego, including a new 57,000-square-foot pharmaceutical manufacturing site and a GMP production suite. This indicates ongoing capacity growth and an increased demand for their manufacturing services, presenting opportunities to offer additional equipment, technology, or service solutions.

Comprehensive Manufacturing Capabilities As a fully integrated CDMO specializing in process development, drug substance manufacturing, and drug product formulation including aseptic fill finish, Althea serves clients across early-stage clinical to commercial production. Partnering with Althea could enable clients to streamline supply chains and reduce manufacturing complexity.

Focus on Biopharma Markets With a focus on biopharmaceutical contract manufacturing, especially in high potency products, Althea is positioned to support innovative biotech and pharma companies seeking reliable partners for complex formulations and manufacturing challenges, opening avenues for specialized equipment and service sales.

Established Industry Presence Operating within the competitive biotech manufacturing space with revenues estimated between $100M and $250M, Althea’s scale and experience establish it as a key player. This provides opportunities for technology vendors, service providers, or consultants aiming to collaborate with a recognized leader in biopharma manufacturing.

Advanced Technology Stack Utilizing modern web and data analytics tools like Heap and PHP, Althea demonstrates a tech-savvy operational approach. This suggests openness to adopting innovative solutions in manufacturing processes, digital transformation initiatives, or data-driven quality management systems to enhance efficiency.